Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08GOI
|
|||
| Drug Name |
FT596
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-10: C81-C86; ICD-9: 202] | Phase 1 | [1] | |
| Company |
Fate Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04245722) FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.